Triple receptor agonist peptide (GLP-1 / GIP / glucagon). EU-manufactured under MSSPT.

For research use only.

Retatrutide is a 39-amino acid peptide engineered from a GIP peptide backbone to stimulate GLP-1, GIP, and glucagon receptors simultaneously. 

It is the first compound in its class with published clinical data and is used in research investigating metabolic regulation, energy expenditure, and hepatic fat dynamics.

Research Applications

• Energy expenditure and metabolic rate
• Adipose tissue and weight regulation models
  
• Glycemic control and insulin sensitivity
• Hepatic fat metabolism and MASH research
• Comparative incretin pathway studies (vs. dual and single agonists)